Investigating the Effect of Aloe vera Gel on the Buccal Permeability of Didanosine

Abstract

The buccal mucosal route offers several advantages but the delivery of certain drugs can be limited by low membrane permeability. This study investigated the buccal permeability properties of didanosine (ddI) and assessed the potential of Aloe vera gel (AVgel) as a novel buccal permeation enhancer. Permeation studies were performed using Franz diffusion cells, and the drug was quantified by UV spectroscopy. Histomorphological evaluations were undertaken using light and transmission electron microscopy. The permeability of ddI was concentration-dependent, and it did not have any adverse effects on the buccal mucosae. A linear relationship (R² = 0.9557) between the concentrations and flux indicated passive diffusion as the mechanism of drug transport. AVgel at concentrations of 0.25 to 2 %w/v enhanced ddI permeability with enhancement ratios from 5.09 (0.25 %w/v) to 11.78 (2 %w/v) but decreased permeability at 4 and 6 %w/v. Ultrastructural analysis of the buccal mucosae treated with phosphate buffer saline pH 7.4 (PBS), ddI/PBS, and ddI/PBS/AVgel 0.5 %w/v showed cells with normal plasmalemma, well-developed cristae, and nuclei with regular nuclear envelopes. However, cells from 1, 2, and 6 %w/v AVgel-treated mucosae showed irregular nuclear outlines, increased intercellular spacing, and plasmalemma crenulations. This study demonstrates the potential of AVgel as a buccal permeation enhancer for ddI to improve anti-HIV and AIDS therapy.

buccal - didanosine - permeation enhancer - histomorphology - Aloe vera (L.) Burm. F. - Aloe barbadensis Miller - Asphodelaceae

References

• 1 Rathbun R C, Lockhart S M, Stephens J R. Current HIV treatment guidelines – an overview.  Curr Pharm Des. 2006;  12 1045-1063
• 2 Heyer A, Ogunbanjo G A. Adherence to HIV antiretroviral therapy Part II: which interventions are effective in improving adherence?.  SA Fam Pract. 2006;  48 6-10
• 3 Xiang J, Fang X, Li X. Transbuccal delivery of 2′,3′-dideoxycytidine: in vitro permeation study and histological investigation.  Int J Pharm. 2002;  231 57-66
• 4 Li X, Chan W K. Transport, metabolism and elimination mechanisms of anti-HIV agents.  Adv Drug Deliv Rev. 1999;  39 81-103
• 5 Pather S I, Rathbone M J, Senel S. Current status and the future of buccal drug delivery systems.  Expert Opin Drug Deliv. 2008;  5 531-542
• 6 Rossi S, Sandri G, Caramella C M. Buccal drug delivery: A challenge already won?.  Drug Discov Today Technol. 2005;  2 59-65
• 7 Salamat-Miller N, Chittchang M, Johnston T P. The use of mucoadhesive polymers in buccal drug delivery.  Adv Drug Deliv Rev. 2005;  57 1666-1691
• 8 Narishetty S T K, Panchagnula R. Effect of L-menthol and 1,8-cineole on phase behaviour and molecular organization of SC lipids and skin permeation of zidovudine.  J Control Release. 2005;  102 59-70
• 9 Mukherji E, Millenbaugh N J, Au J L. Percutaneous absorption of 2′,3′-dideoxyinosine in rats.  Pharm Res. 1994;  11 809-815
• 10 Giannola L I, De Caro V, Giandalia G, Siragusa M G, Tripodo C, Florena A M, Campisi G. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design.  Eur J Pharm Biopharm. 2007;  67 425-433
• 11 Senel S, Hincal A A. Drug permeation enhancement via buccal route: possibilities and limitations.  J Control Release. 2001;  72 133-144
• 12 Femenia A, Sánchez E S, Simal S, Rosselló C. Compositional features of polysaccharides from Aloe vera (Aloe barbadensis Miller) plant tissues.  Carbohydr Polym. 1999;  39 109-117
• 13 Chen W, Lu Z, Viljoen A, Hamman J. Intestinal drug transport enhancement by Aloe vera.  Planta Med. 2009;  75 587-595
• 14 Reynolds T, Dweck A C. Aloe vera leaf gel: a review update.  J Ethnopharmacol. 1999;  68 3-37
• 15 Boudreau M D, Beland F A. An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera.  J Environ Sci Health C. 2006;  24 103-154
• 16 Pugh N, Ross S A, ElSohly M A, Pasco D S. Characterization of aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity.  J Agric Food Chem. 2001;  49 1030-1034
• 17 Cole L, Heard C. Skin permeation enhancement potential of Aloe vera and a proposed mechanism of action based upon size exclusion and pull effect.  Int J Pharm. 2007;  333 10-16
• 18 Jani G K, Shah D P, Jain V C, Patel M J, Vithalan D A. Evaluating mucilage from Aloe barbadensis Miller as a pharmaceutical excipient for sustained-release matrix tablets.  Pharm Technol. 2007;  31 90-98
• 19 Giannola L I, De Caro V, Giandalia G, Siragusa M G, Campisi G, Florena A M, Ciach T. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features.  Eur J Pharm Biopharm. 2007;  65 238-246
• 20 Koland M, Sandeep V P, Charyulu N R. Fast dissolving sublingual films of ondansetron hydrochloride: effect of additives on in vitro drug release and mucosal permeation.  J Young Pharm. 2010;  2 216-222
• 21 Shojaei A H, Khan M, Lim G, Khosravan R. Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer.  Int J Pharm. 1999;  192 139-146
• 22 Karnovsky M J. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy.  J Cell Biol. 1965;  27 137A-138A
• 23 Mahalingam R, Ravivarapu H, Redhkar S, Li X, Jasti B R. Transbuccal delivery of 5-aza-2-deoxycytidine: effects of drug concentration, buffer solution, and bile salts on permeation.  AAPS PharmSciTech. 2007;  8 (55) E1-E6
• 24 Heemstra L B, Finnin B C, Nicolazzo J A. Buccal mucosa as an alternative route for the systemic delivery of risperidone.  J Pharm Sci. 2010;  99 4584-4592
• 25 Hassan N, Ahad A, Ali M, Ali J. Chemical permeation enhancers for transbuccal drug delivery.  Expert Opin Drug Deliv. 2010;  7 97-112
• 26 Sandri G, Poggi P, Bonferoni M C, Rossi S, Ferrari F, Caramella C. Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan.  J Pharm Pharmacol. 2006;  58 1327-1336
• 27 Hu L, Damaj B B, Martin R, Michniak-Kohn B B. Enhanced in vitro transbuccal drug delivery of ondansetron HCl.  Int J Pharm. 2011;  404 66-74
• 28 Sandri G, Rossi S, Bonferoni M C, Ferrari F, Zambito Y, Di Colo G. Buccal penetration enhancement properties of N-trimethyl chitosan: Influence of quaternization degree on absorption of a high molecular weight molecule.  Int J Pharm. 2005;  297 146-155
• 29 Shin S, Cho C, Oh I. Enhanced efficacy by percutaneous absorption of piroxicam from the ploxamer gel in rats.  Int J Pharm. 2000;  193 213-218
• 30 Shin S, Kim J. Enhanced permeation of triamcinolone acetonide through the buccal mucosa.  Eur J Pharm Biopharm. 2000;  50 217-220
• 31 Figueiras A, Hombach J, Veiga F, Bernkop-Schnürch A. In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery.  Eur J Pharm Biopharm. 2009;  71 339-345
• 32 de Vries M E, Boddé H E, Verhoef J C, Ponee M, Craane W I H M, Junginger H E. Localization of the permeability barrier inside porcine buccal mucosa: a combined in vitro study of drug permeability, electrical resistance and tissue morphology.  Int J Pharm. 1991;  76 25-35
• 33 Madhav N V S, Shakya A K, Shakya P, Singh K. Orotransmucosal drug delivery systems: a review.  J Control Release. 2009;  140 2-11
• 34 Dorr W, Jacubek A, Kummermehr J, Herrmann T, Dolling-Jochem I, Eckelt U. Effects of stimulated repopulation on oral mucositis during conventional radiotherapy.  Radiother Oncol. 1995;  37 100-107